Financhill
Back

iShares Core S&P 500 ETF Vs. Keros Therapeutics Industry Stock Comparison

Buy
75

IVV
iShares Core S&P 500 ETF

Last Price:
548.42
Seasonality Move:
0.54%
Sell
25

KROS
Keros Therapeutics

Last Price:
45.47
Seasonality Move:
4.22%
Buy
75
iShares Core S&P 500 ETF (IVV) is a Buy

Is iShares Core S&P 500 ETF a Buy, Sell or Hold?

  • The current iShares Core S&P 500 ETF [IVV] share price is $547.68. The Score for IVV is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • IVV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IVV Stock Price Chart

What is iShares Core S&P 500 ETF's stock price today?

  • The iShares Core S&P 500 ETF share price today is $547.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVV is experiencing buying pressure, which is a positive indicator for future bullish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

IVV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.99 Buy
Relative Strength Index (14 RSI): 68.94 Buy
Chaikin Money Flow: 3174901 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (530.47 - 544.91) Buy
Bollinger Bands (100): (504.84 - 533.2) Buy

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.91 Sell
Relative Strength Index (14 RSI): 36.74 Sell
Chaikin Money Flow: -120480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.18 - 50.06) Sell
Bollinger Bands (100): (50.42 - 64.92) Sell

IVV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 546.72 Buy
20-day SMA: 539.11 Buy
50-day SMA: 525.68 Buy
200-day SMA: 486.29 Buy
8-day EMA: 545.69 Buy
20-day EMA: 540.32 Buy
50-day EMA: 530.24 Buy
200-day EMA: 494.51 Buy

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Sell
20-day SMA: 47.57 Sell
50-day SMA: 52.43 Sell
200-day SMA: 46.94 Sell
8-day EMA: 46.46 Sell
20-day EMA: 48 Sell
50-day EMA: 51.59 Sell
200-day EMA: 50.14 Sell

iShares Core S&P 500 ETF Earnings Growth & IVV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

iShares Core S&P 500 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):